230 related articles for article (PubMed ID: 20067378)
1. Metastatic phenotype is regulated by estrogen in thyroid cells.
Rajoria S; Suriano R; Shanmugam A; Wilson YL; Schantz SP; Geliebter J; Tiwari RK
Thyroid; 2010 Jan; 20(1):33-41. PubMed ID: 20067378
[TBL] [Abstract][Full Text] [Related]
2. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
3. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
Zeng Q; Chen G; Vlantis A; Tse G; van Hasselt C
J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.
Kumar A; Klinge CM; Goldstein RE
Int J Oncol; 2010 May; 36(5):1067-80. PubMed ID: 20372779
[TBL] [Abstract][Full Text] [Related]
5. [Effects of UHRF1 on Estrogen Receptor and Proliferation, Invasion and Migration of BCPAP Cells in Thyroid Papillary Carcinoma].
Xu LW; Zhang LY; Gou X; Qiu YB; Liu ZM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):325-330. PubMed ID: 32543137
[TBL] [Abstract][Full Text] [Related]
6. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
Rajoria S; Suriano R; George A; Shanmugam A; Schantz SP; Geliebter J; Tiwari RK
PLoS One; 2011 Jan; 6(1):e15879. PubMed ID: 21267453
[TBL] [Abstract][Full Text] [Related]
7. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer.
Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG
Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway.
Zhang Y; Wei F; Zhang J; Hao L; Jiang J; Dang L; Mei D; Fan S; Yu Y; Jiang L
Arch Biochem Biophys; 2017 Nov; 633():29-39. PubMed ID: 28882636
[TBL] [Abstract][Full Text] [Related]
9. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor (ER)-beta, but not ER-alpha, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma.
Ceresini G; Morganti S; Graiani V; Saccani M; Milli B; Usberti E; Valenti G; Ceda GP; Corcione L
Thyroid; 2006 Dec; 16(12):1215-20. PubMed ID: 17199431
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells.
Catalano MG; Fortunati N; Pugliese M; Marano F; Ortoleva L; Poli R; Asioli S; Bandino A; Palestini N; Grange C; Bussolati B; Boccuzzi G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1150-9. PubMed ID: 22563106
[TBL] [Abstract][Full Text] [Related]
12. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.
Park SH; Cheung LW; Wong AS; Leung PC
Mol Endocrinol; 2008 Sep; 22(9):2085-98. PubMed ID: 18550773
[TBL] [Abstract][Full Text] [Related]
13. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma.
Ishida H; Wada K; Masuda T; Okura M; Kohama K; Sano Y; Nakajima A; Kogo M; Kamisaki Y
Cancer Sci; 2007 May; 98(5):636-43. PubMed ID: 17355262
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
15. Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion.
White PT; Subramanian C; Zhu Q; Zhang H; Zhao H; Gallagher R; Timmermann BN; Blagg BS; Cohen MS
Surgery; 2016 Jan; 159(1):142-51. PubMed ID: 26542767
[TBL] [Abstract][Full Text] [Related]
16. BRAFV600E Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors.
Kim M; Kim SJ; Ha SY; Xu Z; Han Y; Jee HG; Cho SW; Park YJ; Lee KE
Endocrinol Metab (Seoul); 2022 Dec; 37(6):879-890. PubMed ID: 36604958
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of estrogen receptors in thyroid lesions.
Vaiman M; Olevson Y; Habler L; Kessler A; Zehavi S; Sandbank J
Med Sci Monit; 2010 Jul; 16(7):BR203-7. PubMed ID: 20581768
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.
Di Vito M; De Santis E; Perrone GA; Mari E; Giordano MC; De Antoni E; Coppola L; Fadda G; Tafani M; Carpi A; Russo MA
Cancer Sci; 2011 Oct; 102(10):1921-7. PubMed ID: 21707866
[TBL] [Abstract][Full Text] [Related]
19. Estrogen Induces Metastatic Potential of Papillary Thyroid Cancer Cells through Estrogen Receptor α and β.
Dong W; Zhang H; Li J; Guan H; He L; Wang Z; Shan Z; Teng W
Int J Endocrinol; 2013; 2013():941568. PubMed ID: 24222765
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor α/β Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.
Yi JW; Kim SJ; Kim JK; Seong CY; Yu HW; Chai YJ; Choi JY; Lee KE
Ann Surg Oncol; 2017 Nov; 24(12):3754-3762. PubMed ID: 28124274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
